Type-4 Phosphodiesterase (PDE4) Blockade Reduces Neutrophil activation in Behçet's disease.
Alexandre Le JoncourPaul RégnierAnna Maciejewski-DuvalErwan CharlesStéphane BaretePierre FouretMichelle RosenzwajgDavid KlatzmannPatrice CacoubDavid SaadounPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2023)
We pointed out key biological effects of apremilast on neutrophils in BD.
Keyphrases